Walleye Capital LLC Purchases New Stake in Ardent Health, Inc. $ARDT

Key Points

• Walleye Capital LLC acquired 133,188 shares of Ardent Health, Inc. during the first quarter, valuing the investment at approximately $1.83 million.
• Ardent Health reported earnings of $0.52 per share for the recent quarter, exceeding analysts' expectations and setting its FY 2025 guidance between 1.730-2.01 EPS.
• Wall Street analysts have mixed ratings on Ardent Health, with a consensus rating of "Moderate Buy" and a price target averaging around $19.56.

Walleye Capital LLC acquired a new stake in Ardent Health, Inc. (NYSE:ARDT - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 133,188 shares of the company's stock, valued at approximately $1,831,000. Walleye Capital LLC owned 0.09% of Ardent Health at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. Jump Financial LLC bought a new stake in shares of Ardent Health in the 1st quarter valued at about $352,000. Quantbot Technologies LP bought a new stake in shares of Ardent Health in the 1st quarter valued at about $345,000. Nuveen LLC bought a new stake in shares of Ardent Health in the 1st quarter valued at about $6,010,000. Invesco Ltd. bought a new stake in shares of Ardent Health in the 1st quarter valued at about $226,000. Finally, Deutsche Bank AG raised its holdings in shares of Ardent Health by 140.1% in the 1st quarter. Deutsche Bank AG now owns 6,882 shares of the company's stock valued at $95,000 after purchasing an additional 4,016 shares in the last quarter.

Ardent Health Price Performance

ARDT traded up $0.15 during midday trading on Friday, hitting $12.68. 179,767 shares of the company traded hands, compared to its average volume of 388,258. The company has a current ratio of 2.13, a quick ratio of 2.00 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $1.82 billion, a price-to-earnings ratio of 7.01, a PEG ratio of 5.61 and a beta of 0.29. Ardent Health, Inc. has a 52-week low of $10.10 and a 52-week high of $20.72. The business has a 50 day simple moving average of $12.38 and a two-hundred day simple moving average of $13.22.

Ardent Health (NYSE:ARDT - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.30 by $0.22. The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.54 billion. Ardent Health had a net margin of 4.11% and a return on equity of 16.66%. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. On average, equities analysts forecast that Ardent Health, Inc. will post 1.23 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently commented on the stock. Wall Street Zen upgraded shares of Ardent Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 9th. JPMorgan Chase & Co. reduced their price target on shares of Ardent Health from $18.00 to $15.00 and set a "neutral" rating for the company in a report on Monday, August 11th. KeyCorp reduced their price objective on shares of Ardent Health from $24.00 to $20.00 and set an "overweight" rating for the company in a research note on Thursday, August 7th. Guggenheim boosted their price objective on shares of Ardent Health from $16.00 to $18.00 and gave the stock a "buy" rating in a research note on Friday, May 9th. Finally, Bank of America lowered shares of Ardent Health from a "neutral" rating to an "underperform" rating and reduced their price objective for the stock from $15.50 to $14.60 in a research note on Wednesday, July 16th. Eight analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $19.56.

Ardent Health Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.